MENU
+Compare
RVPH
Stock ticker: NASDAQ
AS OF
May 14 closing price
Price
$0.79
Change
-$0.04 (-4.82%)
Capitalization
36.92M

RVPH Reviva Pharmaceuticals Holdings Forecast, Technical & Fundamental Analysis

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases... Show more

RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RVPH with price predictions
May 13, 2025

RVPH's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for RVPH turned positive on April 14, 2025. Looking at past instances where RVPH's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RVPH's RSI Indicator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where RVPH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RVPH advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 79 cases where RVPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RVPH as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for RVPH moved below the 200-day moving average on April 10, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RVPH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (45.455) is normal, around the industry mean (14.386). P/E Ratio (0.000) is within average values for comparable stocks, (64.760). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.146). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (254.479).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RVPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RVPH is expected to report earnings to fall 76.94% to -20 cents per share on May 19

Reviva Pharmaceuticals Holdings RVPH Stock Earnings Reports
Q1'25
Est.
$-0.21
Q4'24
Missed
by $0.67
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.13
The last earnings report on March 31 showed earnings per share of -89 cents, missing the estimate of -22 cents. With 331.98K shares outstanding, the current market capitalization sits at 36.92M.
A.I. Advisor
published General Information

General Information

a blank check company, which focuses on the merger, capital stock exchange, asset acquisition, stock purchase, reorganization, recapitalization, and exchangeable share transaction.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
19925 Stevens Creek Boulevard
Phone
+1 408 501-8881
Employees
10
Web
https://www.revivapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA347.6813.61
+4.07%
Tesla
GME28.730.34
+1.20%
GameStop Corp
SPY587.590.75
+0.13%
SPDR® S&P 500® ETF
AAPL212.33-0.60
-0.28%
Apple
BTC.X103539.414000-630.398440
-0.61%
Bitcoin cryptocurrency

RVPH and Stocks

Correlation & Price change

A.I.dvisor tells us that RVPH and GYRE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVPH and GYRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
+7.40%
GYRE - RVPH
31%
Poorly correlated
+6.19%
CLDX - RVPH
26%
Poorly correlated
-2.78%
INM - RVPH
26%
Poorly correlated
N/A
AFMD - RVPH
25%
Poorly correlated
-80.66%
TCRT - RVPH
24%
Poorly correlated
+1.05%
More